Fig. 3From: Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitisDaily symptom score (DSS) and daily medication score (DMS) in the Canadian subpopulation during the peak ragweed pollen season (FAS population). FAS, full analysis set; SLIT, sublingual immunotherapyBack to article page